Hepatocellular carcinoma CT: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:


==Key CT Findings in Hepatocellular Carcinoma CT Scan==
==Key CT Findings in Hepatocellular Carcinoma CT Scan==
On [[CT]], hepatocellular carcinoma (HCC) is characterized by :
On [[CT]], hepatocellular carcinoma (HCC) is characterized by:<ref name="radiopaedia">http://radiopaedia.org/articles/hepatocellular-carcinoma.http://www.cancer.gov/types/anal/hp/anal-treatment-pdq#section/_36</ref>
*Focal HCC
*Focal HCC
:*large usually hypoattenuating mass
:*large usually hypoattenuating mass
Line 19: Line 19:
*Diffuse HCC
*Diffuse HCC
:*May be difficult to distinguish from associated cirrhosis
:*May be difficult to distinguish from associated cirrhosis
Enhancement pattern is the key to correct assessment of HCCs. Usually the mass enhances vividly during late arterial (~35 seconds) and then washes out, becoming indistinct or hypoattenuating in the portal venous phase, compared to the rest of the liver. 
Additionally, they may be associated with a wedge shaped perfusion abnormality due to arterioportal shunts (APS), and this in turn can result in focal fatty change in the normal liver or focal fatty sparing in the diffusely fatty liver. A halo of focal fatty sparing may also be seen around an HCC in an otherwise fatty liver.


==References==
==References==

Revision as of 18:48, 11 September 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Hepatocellular carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes of Hepatocellular carcinoma

Differentiating Hepatocellular carcinoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic study of choice

History and symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular carcinoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular carcinoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular carcinoma CT

CDC on Hepatocellular carcinoma CT

Hepatocellular carcinoma CT in the news

Blogs on Hepatocellular carcinoma CT

Directions to Hospitals Treating Hepatocellular carcinoma

Risk calculators and risk factors for Hepatocellular carcinoma CT

Overview

Abdominal CT scan with intravenous contrast agent is the best method to diagnose hepatocellular carcinoma. Three-phase scanning (before contrast administration, immediately after contrast administration, and again after a delay) to increase the ability of the radiologist to detect small or subtle tumors. It is important to optimize the parameters of the CT examination, because the underlying liver disease (e.g. hepatitis B) that most hepatocellular carcinoma patients have can make the findings more difficult to appreciate.

Key CT Findings in Hepatocellular Carcinoma CT Scan

On CT, hepatocellular carcinoma (HCC) is characterized by:[1]

  • Focal HCC
  • large usually hypoattenuating mass
  • May have necrosis/fat/calcification
  • Multifocal HCC
  • Multiple masses of variable attenuation lesions
  • May also have central hypoattenuating necrotic portions
  • Diffuse HCC
  • May be difficult to distinguish from associated cirrhosis

References


Template:WikiDoc Sources